SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 26 filers reported holding SALARIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | 0.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -50.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -20.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | -51.2% | 39,746 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $41,000 | -2.4% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | -28.8% | 39,746 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $59,000 | +63.9% | 39,746 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $36,000 | +5.9% | 39,746 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $34,000 | -34.6% | 39,746 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $52,000 | +92.6% | 39,746 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $27,000 | -82.0% | 39,746 | 0.0% | 0.00% | -80.0% |
| Q4 2019 | $150,000 | -44.6% | 39,746 | -20.1% | 0.02% | -46.4% |
| Q3 2019 | $271,000 | – | 49,746 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,354,291 | $1,436,000 | 0.36% |
| AIGH Capital Management LLC | 1,800,000 | $1,909,000 | 0.34% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 471,885 | $500,000 | 0.22% |
| Worth Venture Partners, LLC | 424,800 | $450,000 | 0.17% |
| Maven Securities LTD | 1,316,205 | $1,369,000 | 0.06% |
| X-Square Capital, LLC | 100,458 | $106,000 | 0.05% |
| Kepos Capital LP | 548,054 | $581,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 249,033 | $264,000 | 0.04% |
| Granite Point Capital Management, L.P. | 585,409 | $621,000 | 0.02% |
| 1900 WEALTH MANAGEMENT LLC | 40,000 | $42,000 | 0.00% |